February 13, 2025 10:41 AM EST
News Briefing

Al­lay Ther­a­peu­tics rais­es $45M for on­go­ing Se­ries D; En­cod­ed’s lay­offs

ENDPOINTS

Plus, news about Pli­ant Ther­a­peu­tics, Blue­print Med­i­cines, Gala­pa­gos and Atai:

Pain biotech rais­es $45M: Al­lay Ther­a­peu­tics, which is de­vel­op­ing non-opi­oid anal­gesics pain …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

Trump blog: Judge ex­tends na­tion­wide block on NIH pay­ment cuts

RFK Jr. read­ies re­view of child­hood vac­cine sched­ule af­ter pledg­ing not to

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times